Pfizer to supply Global Fund up to 6 million courses of its COVID antiviral Paxlovid for low-and-middle-income countriesMarket Watch • 09/22/22
Pfizer to Supply Global Fund Up to 6 Million PAXLOVID™ Treatment Courses for Low-and-Middle-Income CountriesBusiness Wire • 09/22/22
Pfizer Invites Public to View and Listen to Webcast of November 1 Conference Call with AnalystsBusiness Wire • 09/20/22
Vaccine stocks Pfizer, BioNTech, Moderna and Novavax slide after Biden says pandemic is overMarket Watch • 09/19/22
Pfizer Announces Positive Top-Line Results from Phase 3 Study in 20-Valent Pneumococcal Conjugate Vaccine in Infants in the European UnionBusiness Wire • 09/19/22
Pfizer, BioNTech COVID vaccine gets CHMP recommendation for 'full' MA for all indicationsMarket Watch • 09/16/22